Overview
Phase II Dose Titration Study in Patients With Neuropathic Pain
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to examine the effects of various increasing doses of Ralfinamide in patients with neuropathic pain.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Newron
Newron Pharmaceuticals SPA
Criteria
Inclusion Criteria:- Male or female patients
- Females post-menopausal for at least 12 months, 24 months in India, Poland, and
Austria
- Diagnosed by neurologist with current neuropathic pain
Exclusion Criteria:
- See inclusion criteria